Yes, these liver lesions require further evaluation with dedicated contrast-enhanced imaging.
For a 67-year-old male with incidentally discovered hepatic lesions on CT urogram (which is typically a single-phase or non-contrast study), the ACR Appropriateness Criteria clearly recommend proceeding with either multiphase contrast-enhanced CT or MRI with and without IV contrast to characterize these lesions 1.
Why Further Evaluation is Necessary
The CT urogram is not designed for liver lesion characterization—it lacks the multiphase contrast enhancement patterns needed to differentiate benign from malignant lesions. Without proper characterization:
- Contrast-enhanced CT can only differentiate benign from malignant lesions in 74-95% of cases when performed with appropriate multiphase technique 1
- MRI with contrast achieves 95% definitive diagnosis rates and requires additional imaging in only 1.5% of cases (compared to 10% with CT) 1
- Uncharacterized lesions carry diagnostic uncertainty that can only be resolved through dedicated imaging
Recommended Next Steps
First-Line Imaging Options (Choose One):
Option 1: Multiphase Contrast-Enhanced CT Abdomen
- Provides 91-95% accuracy for hemangioma diagnosis
- 85-93% accuracy for focal nodular hyperplasia (FNH)
- 96-99% accuracy for hepatocellular carcinoma (HCC) 1
Option 2: MRI Abdomen Without and With IV Contrast (Preferred)
- Superior diagnostic performance: 95% definitive diagnosis rate 1
- Gadoxetate-enhanced MRI achieves 95-99% accuracy for hemangioma, 88-99% for FNH, and 97% for HCC 1
- Combination of diffusion-weighted imaging (DWI) and hepatobiliary phase correctly classifies lesions as benign or malignant in 91% of cases 1
Critical Clinical Context Needed
Before proceeding, assess these risk factors that significantly influence management 2:
- History of any malignancy (changes algorithm to higher suspicion pathway)
- Hepatitis B or C status (increases malignancy risk)
- Elevated tumor markers (AFP, CEA, CA 19-9)
- Chronic liver disease or cirrhosis (dramatically increases HCC risk)
Important Note on Risk Stratification:
In asymptomatic patients without these four risk factors, malignancy is exceedingly rare (0% in one study of 542 patients) 2. However, at age 67, occult malignancy risk increases, making characterization still prudent.
Common Pitfalls to Avoid
- Do not assume benignity without proper imaging: Even "typical-appearing" lesions on single-phase CT can be malignant
- Do not order CT with and without contrast: The unenhanced phase adds no diagnostic value in this scenario 1
- Do not proceed directly to biopsy: Imaging should precede biopsy to avoid unnecessary procedures on benign lesions like hemangiomas or FNH, and to avoid 9-12% bleeding risk with hypervascular lesions 1
If Lesions Remain Indeterminate After Initial Advanced Imaging
- Contrast-enhanced ultrasound (CEUS) can achieve 98.7% accuracy in CT-undetermined lesions 3
- Percutaneous biopsy may be necessary if imaging suggests malignancy, with success rates of 96-100% under appropriate guidance 1
The bottom line: Do not leave these lesions uncharacterized. The initial CT urogram is insufficient for diagnosis, and proceeding with dedicated multiphase imaging is the standard of care 1.